Genoway Net Income Applicable To Common Shares from 2010 to 2026
| ALGEN Stock | EUR 2.49 0.04 1.63% |
Net Income Applicable To Common Shares | First Reported 2016-09-30 | Previous Quarter 706.3 K | Current Value 1.1 M | Quarterly Volatility 407.8 K |
Check Genoway financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genoway's main balance sheet or income statement drivers, such as Interest Expense of 168.4 K, Total Revenue of 26.6 M or Cost Of Revenue of 15.5 M, as well as many indicators such as Price To Sales Ratio of 1.23, Dividend Yield of 0.0 or PTB Ratio of 2.56. Genoway financial statements analysis is a perfect complement when working with Genoway Valuation or Volatility modules.
Genoway | Net Income Applicable To Common Shares |
Evaluating Genoway's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Genoway's fundamental strength.
Latest Genoway's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Genoway over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Genoway's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genoway's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Genoway Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 631,591 | |
| Coefficient Of Variation | 155.34 | |
| Mean Deviation | 780,419 | |
| Median | 502,000 | |
| Standard Deviation | 981,112 | |
| Sample Variance | 962.6B | |
| Range | 3.2M | |
| R-Value | 0.51 | |
| Mean Square Error | 760.9B | |
| R-Squared | 0.26 | |
| Significance | 0.04 | |
| Slope | 98,865 | |
| Total Sum of Squares | 15.4T |
Genoway Net Income Applicable To Common Shares History
About Genoway Financial Statements
Genoway shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Genoway investors may analyze each financial statement separately, they are all interrelated. The changes in Genoway's assets and liabilities, for example, are also reflected in the revenues and expenses on on Genoway's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 2.1 M | 2.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genoway Stock Analysis
When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.